Active, Not Recruiting
Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)
NCT03992417
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
- Locations
-
- Investigational Site Number : 0320013 Pilar, Buenos Aires, Argentina
- Investigational Site Number : 0320012 Rosario, Santa Fe Province, Argentina
- Investigational Site Number : 0320011 Ciudad Autonoma Bs As, Argentina
- Investigational Site Number : 0360002 Kogarah, New South Wales, Australia